Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

NCT00978237 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Lipoatrophy

Interventions

DRUG: EFV
DRUG: LPV/r

Sponsor

Juan A. Arnaiz